100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
NR603 Week 3 Focus Quiz Topics / NR 603 Week 3 Focus Quiz Topics :Chamberlain College of Nursing (NEW-2022)( Download to score A) $8.49   Add to cart

Other

NR603 Week 3 Focus Quiz Topics / NR 603 Week 3 Focus Quiz Topics :Chamberlain College of Nursing (NEW-2022)( Download to score A)

 2 views  0 purchase
  • Course
  • Institution

NR603 Week 3 Focus Quiz Topics / NR 603 Week 3 Focus Quiz Topics :Chamberlain College of Nursing (NEW-2022)( Download to score A)

Preview 2 out of 14  pages

  • February 2, 2022
  • 14
  • 2021/2022
  • Other
  • Unknown
avatar-seller
1
NR 603 WK 3 FOCUS QUIZ TOPICS

NR 603 Week 3 Focus Quiz Topics
WEEK 3 QUIZ – CH 116, 188-122, 126 AND 211 Primary care a collaborative practice
Heart Failure (ch 121)
Congestive heart failure (CHF) risks
- HTN - MI, CAD - DM - Metabolic syndrome
- Drug Abuse - PVD - Valvular heart disease. - Cardiomyopathies

CHF typical presentation
- Fatigue - decrease in exercise tolerance - SOB - Cough, rales
- JVD/edema - Palpitations - Anorexia, early satiety
- Wt gain >2 lb in 1 day >5 lb in 1 wk
- AMS (elderly) - S3

NYHA Classification of CHF
* Class I*********Cardiac disease without resulting limitation of physical activity

* Class II*******Slight limitation of physical activity - comfortable at rest, but ordinary physical activity results in
fatigue, palpitation, dyspnea, or anginal pain

* Class III******Marked limitations in physical activity - comfortable at rest, but less than ordinary physical
activity causes fatigue, palpitation, dyspnea, or anginal pain

* Class IV******Inability to carry on any physical activity without discomfort - or symptoms at rest
AHA/ACC 2009 - staging system of heart




HFrEF stands for
- Heart failure with reduced ejection fraction (EF < 40%) - Systolic failure
HFpEF stands for
- Heart failure with preserved ejection fraction - Varying definitions: EF > 40, 45, 50, or 55%. - Diastolic failure
HFmrEF stands for
- Heart failure with mid-range ejection fraction - EF 40-49%
CHF Diagnosis orders
* CXR. * CBC, CMP, UA. * Lipid profile. * TSH
* BNP (B-type natriuretic peptide)
- 200-400 pg/ml - likely moderate CHF - > 400 pg/ml - likely moderate to severe CHF - poorer prognosis
- Not part of routine OP eval
- Useful in acute dyspnea to r/o CHF
* Cardiac enzymes * EKG * Echo/TEE

, 2
NR 603 WK 3 FOCUS QUIZ TOPICS
CHF treatment & management
* Meds - start w at least two

- ACEI * Mainstay of therapy * if K < 5.5

- Beta-blockers * Carvedolol (Coreg)

- Aldosterone antagonists * Aldactone 25-50 mg po daily (target)

- Diuretics - symptom mgmt. * Lasix po or IV * Zaroxolyn (good addition if lasix insufficient)

- Digoxin

- Statin if hx MI

* Referral
CHF treatment & management : ACE targets
- linisopril 20-35 mg daily - enalopril 10-20 mg BID
- captopril 50 mg TID - ramipril 5 mg BID (10 mg daily)
CHF treatment & management : Beta blocker targets
* Carvedilol 25-50 mg BID 50 mg BID if > 85 kg

* Metoprolol 150-200 mg daily

* Bisoprolol 5-10 mg daily 10 mg qd if > 85 kg
**CHF treatment & management : 2016 guidelines**
* ACEI - first line; ARB – second - Level 1A evidence

* ARNI - ARB combined w neprilysin
- Neprilysin degrades natriuretic peptides, bradykinin, adrenomedullin and other vasoactive peptides. (Eg.
valsaran/sacubitril - Entresto - target 97/103 mg BID)
- RCT - reduced composite endpoint of CV death or hospitalization by 20% - Caution - hypotension, renal
insufficiency; angioedema
- Replaces ACE or ARB - stop - minimum 36 hour washout - Use in chronic symptomatic HFrEF (< 40%) NYHA
class II or III
Other management guidelines for CHF
* Risk reduction - HTN, lipids, obesity, DM, tobacco use, known cardiotoxic agents
* Sodium restriction (ideally 1500 mg) * Treatment of sleep disorders/OSA
* Wt loss if morbidly obese * Exercise & cardiac rehab
* Anticoagulation in Afib * Statins only if hx of MI or meet other criteria
* Omega-3 supplementation - 10-20% reduction in risk of fatal/non-fatal CV event in HF
Top 10 challenges of CHF management
* Recognize HF signs & symptoms

* Treat reversible causes - Ischemia, CAD, valve dysfunction, thyroid, A-fib, OSA

* Initiate proven therapies - ACEI & B-blockers

* Reach target doses of meds

* Distinguish ACE cough
- ACE - dry, hacking, doesn't change with position - CHF - moist, worse with recumbency

* Monitor lytes when starting or changing drug doses

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller EXAMTUTOR. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75323 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$8.49
  • (0)
  Add to cart